CLNO, ASTM, SFIO, TRUE, EFOI - CRWEWallstreet.com Stock Report! March 29th 2011

Mar. 29, 2011 12:13 PM ET
Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Contributor Since 2011

signup3m

http://crwewallstreet.com/img/line1.png

Aastrom Biosciences, Inc. (Nasdaq:ASTM) a leading developer of expanded, patient specific cellular therapies for the treatment of severe, chronic cardiovascular diseases, announced that the company will hold its 2011 Annual Meeting of Shareholders on June 7, 2011, at 8:30 A.M. (EDT) at the company's headquarters in Ann Arbor, Michigan. Shareholders of record as of April 11, 2011, are entitled to notice of and to vote at the meeting. Aastrom plans to file the definitive proxy statement for the Annual Meeting on April 12, 2011.

Aastrom Biosciences, Inc., a regenerative medicine company, engages in developing autologous cell therapies for the treatment of severe and chronic cardiovascular diseases.

http://crwewallstreet.com/img/line1.png

http://crwewallstreet.com/img/clno_logo_01.jpg

Cleantech Transit Inc. ("Cleantech") (OTCBB:CLNO) was founded to capitalize on technology advances and manufacturing opportunities in the growing clean energy public transportation sector. The Company has expanded its focus to invest directly in specific green projects that can maximize shareholder value. Recognizing the many economic and operational advances of converting wood waste into renewable sources of energy, Cleantech has selected to invest in Phoenix Energy (phoenixenergy.net). This project can generate shareholder returns as well benefit the Company's manufacturing clients worldwide.

Biomass, a renewable energy source, is biological material from living, or recently living organisms, such as wood, waste, (hydrogen) gas, and alcohol fuels.

Example of Successful Wood-Waste-to-Energy Applications: Wood-Fired Cogeneration Provides Reliable Off-Grid Power for Maryland Correctional Facility

Read more at: http://crwewallstreet.com/?p=17115

Recommended For You

Comments

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.